194 related articles for article (PubMed ID: 31625766)
1. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
Wysham CH; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Duh MS; Young JB
Curr Med Res Opin; 2020 Feb; 36(2):219-227. PubMed ID: 31625766
[No Abstract] [Full Text] [Related]
2. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
[TBL] [Abstract][Full Text] [Related]
3. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
4. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
[TBL] [Abstract][Full Text] [Related]
5. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
[TBL] [Abstract][Full Text] [Related]
6. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
[TBL] [Abstract][Full Text] [Related]
7. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
[TBL] [Abstract][Full Text] [Related]
9. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
[TBL] [Abstract][Full Text] [Related]
10. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
11. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study.
Liu JJ; Liu S; Gurung RL; Ang K; Tang WE; Sum CF; Tavintharan S; Lim SC
Nephrol Dial Transplant; 2020 Jan; 35(1):115-121. PubMed ID: 30007296
[TBL] [Abstract][Full Text] [Related]
12. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
Penno G; Garofolo M; Del Prato S
Nutr Metab Cardiovasc Dis; 2016 May; 26(5):361-73. PubMed ID: 27105869
[TBL] [Abstract][Full Text] [Related]
14. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of normoalbuminuria and renal impairment in type 2 diabetes mellitus
.
Pichaiwong W; Homsuwan W; Leelahavanichkul A
Clin Nephrol; 2019 Aug; 92(2):73-80. PubMed ID: 31198168
[TBL] [Abstract][Full Text] [Related]
16. Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.
Kavuru V; Senger RS; Robertson JL; Choudhury D
PeerJ; 2023; 11():e14879. PubMed ID: 36874959
[TBL] [Abstract][Full Text] [Related]
17. Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single-centre retrospective study in Beijing.
Sui Z; Wang J; Cabrera C; Wei J; Wang M; Zuo L
Nephrology (Carlton); 2020 Sep; 25(9):714-722. PubMed ID: 32180286
[TBL] [Abstract][Full Text] [Related]
18. Association of the rs5186 polymorphism of the AGTR1 gene with decreased eGFR in patients with type 2 diabetes from Mexico City.
Figueroa MAC; Lujambio IM; Gutiérrez TA; Hernández MFP; Ramírez EYE; Guzmán DJ; Sánchez MFL; Morales HFG; Samudio HJG; Sánchez FS; Flores MD; Zamarripa CAJ; Mendoza CCC; Hernández MEO; Velázquez CMO; Flores MS; Orozco DVH; Moreno GYC; Cruz M; de Jesús Peralta Romero J
Nefrologia (Engl Ed); 2023; 43(5):546-561. PubMed ID: 37996337
[TBL] [Abstract][Full Text] [Related]
19. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
Chen PM; Wada T; Chiang CK
Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
